Contact Person
David Munis Zepernick

Head of Communication and Public Affairs

Email: dz@mva.org
Phone: (M) +45 2498 1668
Linkedin

News

Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.

MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.

If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.

21 Feb

MVA-member, Ascelia Pharma, publishes prospectus in connection with Initial Public Offering on Nasdaq Stockholm

“Ascelia Pharma is in a very exciting phase, especially with our main product candidate Mangoral, which is approaching clinical Phase III development and market launch. Meanwhile, we are continuing the development of our second product candidate Oncoral, which completed Phase

15 Feb

MVA Chairman of the Board of Directors new Chief Business Officer at IO Biotech

Medicon Valley Alliance´s Chairman of the Board since 2015, Søren Bregenholt, has recently been appointed Chief Business Officer at IO Biotech. Leading Danish life science media, Medwatch, interviewed “Novo Nordisk-veteran”, Søren Bregenholt, about his new position and about going from

15 Feb

Synapse – Life Science Connect: Invitation for Copenhagen Life Science Summit ’19

Our friends at Synapse – Life Science Connect will be hosting the Copenhagen Life Science Summit ’19 (CLSS) on Thursday, May 9th at The Exchange Hall (Børssalen). A full-day conference that aims to bring together students, recent graduates and professionals to

04 Feb

The Danish capital’s entrepreneurial ecosystem is unique according to Daiichi Sankyo´s Global Chief of Research and Development, Antoine Yver

COBIS-based MVA-member, Japanese oncology company, Daiichi Sankyo, established their Nordic headquarter in Copenhagen last year.  This was absolutely no coincidence according to Daiichi Sankyo´s Global Chief of Research and Development, Antoine Yver (standing left), who motivates their decision in a recently

22 Jan

Medicon Valley Alliance member company, Chr. Hansen, ranked as the most sustainable company in the world

During the World Economic Forum in Davos, Switzerland, the Danish based bioscience company, Chr. Hansen,  that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries was ranked as the most sustainable company in the world by the recognized business

21 Jan

Cobis-based Bio Innovation Institute picks the first 8 winners of the Proof of Concept grant

More than 70 projects applied for the Bio Innovation Institute Proof of Concept grant of up to DKK 1M. 8 projects were finally awarded a total of DKK 7.5M. Here are the winners. We at Medicon Valley Alliance wish them the best

04 Jan

Business Ballerup launches new campaign to attract life science investors and companies

Municipality of Ballerup, MVA-member and one of the leading Danish life science municipalities, has just launched a new campaign and promotion video to raise awareness of the opportunity to locate your life science company in the vibrant local life science

13 Dec

Medicon Valley Alliance is part of the new German-Scandinavian cross-border research network project ‘Hanseatic League of Science

Medicon Valley Alliance is part of the new German-Scandinavian cross-border research network project ‘Hanseatic League of Science (HALOS)’ that has been awarded 3.6 million Euro by the European Regional Development Fund INTERREG. The project, which is coordinated by the University

06 Dec

ReproUnion has been granted funding for the continuance of the ReproUnion project– we call it ReproUnion 2.0.

We are happy to be able to announce that ReproUnion has been granted funding for the continuance of the ReproUnion project, which will help establish and further develop the Medicon Valley region as a world-class life science cluster within infertility